Edition:
United States

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

125.54USD
27 Mar 2017
Change (% chg)

$0.06 (+0.05%)
Prev Close
$125.48
Open
$125.37
Day's High
$126.14
Day's Low
$125.16
Volume
277,147
Avg. Vol
2,377,518
52-wk High
$129.00
52-wk Low
$107.70

McClellan, Mark 

Dr. Mark B. McClellan, M.D., Ph.D. is a Independent Director of Johnson & Johnson. He joined the Board of Directors in 2013, and is a member of the Regulatory, Compliance & Government Affairs Committee and the Science, Technology & Sustainability Committee. Dr. McClellan became the inaugural Director of the Duke-Robert J. Margolis, MD, Center for Health Policy in January 2016, and the Margolis Professor of Business, Medicine and Health Policy at Duke University. He is also a faculty member at Dell Medical School at The University of Texas in Austin. Previously, he served from 2007 to 2015 as a Senior Fellow in Economic Studies, and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, and as Commissioner of the U.S. Food and Drug Administration from 2002 to 2004. He served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House from 2001 to 2002, and during President Bill Clinton’s administration, held the position of Deputy Assistant Secretary for Economic Policy for the Department of the Treasury. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the Food and Drug Administration, is a member of the National Academy of Medicine and chairs the Academy’s Leadership Council for Value and Science-Driven Health Care, and co-chairs the guiding committee of the Health Care Payment Learning and Action Network.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

23,795,900

Dominic Caruso

9,689,400

Sandra Peterson

7,626,450

Peter Fasolo

3,621,280

Paulus Stoffels

10,785,700

Michael Ullmann

5,676,350
As Of  2 Jan 2016